BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16144797)

  • 1. Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus.
    Male C; Foulon D; Hoogendoorn H; Vegh P; Silverman E; David M; Mitchell L
    Blood; 2005 Dec; 106(13):4152-8. PubMed ID: 16144797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus.
    Male C; Mitchell L; Julian J; Vegh P; Joshua P; Adams M; David M; Andrew ME
    Blood; 2001 Feb; 97(4):844-9. PubMed ID: 11159506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid antibodies in children with systemic lupus erythematosus: a long-term clinical and laboratory follow-up status study from northwest India.
    Ahluwalia J; Singh S; Naseem S; Suri D; Rawat A; Gupta A; Masih J; Bose S
    Rheumatol Int; 2014 May; 34(5):669-73. PubMed ID: 23563494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of disease expression in SLE patients with antiphospholipid antibodies: data from Indian Systemic Lupus Erythematosus Inception cohort (INSPIRE).
    Shobha V; Rajasekhar L; Manuel S; Nayana V; Kavadichanda C; Kounassegarane D; Mathew AJ; Gupta R; Rathi M; Ghosh P; Tripathy SR; Das B; Selvam S; Singh AK; Singh A; Jain A; Aggarwal A
    Rheumatol Int; 2024 May; 44(5):819-829. PubMed ID: 38082159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study.
    Berube C; Mitchell L; Silverman E; David M; Saint Cyr C; Laxer R; Adams M; Vegh P; Andrew M
    Pediatr Res; 1998 Sep; 44(3):351-6. PubMed ID: 9727712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibody profiles and their clinical associations in Chinese patients with systemic lupus erythematosus.
    Mok MY; Chan EY; Fong DY; Leung KF; Wong WS; Lau CS
    J Rheumatol; 2005 Apr; 32(4):622-8. PubMed ID: 15801016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
    Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O
    J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
    Lee SS; Cho ML; Joo YS; Kim WU; Hong YS; Min JK; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies in children with systemic lupus erythematosus: a prospective study in northern India.
    Ahluwalia J; Singh S; Garewal G
    Rheumatol Int; 2005 Sep; 25(7):530-5. PubMed ID: 15338189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study.
    Zamora-Medina MDC; Hinojosa-Azaola A; Nuñez-Alvarez CA; Vargas-Ruiz AG; Romero-Diaz J
    Clin Rheumatol; 2019 Mar; 38(3):885-893. PubMed ID: 30515663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis.
    Reynaud Q; Lega JC; Mismetti P; Chapelle C; Wahl D; Cathébras P; Laporte S
    Autoimmun Rev; 2014 Jun; 13(6):595-608. PubMed ID: 24418303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study.
    Sciascia S; Radin M; Cecchi I; Rubini E; Foddai SG; Barinotti A; Vaccarino A; Rossi D; Roccatello D
    Front Med (Lausanne); 2021; 8():621590. PubMed ID: 33598471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.